Following the frequent suspicions regarding the safety of cholesterol-lowering drugs in the pre-statin era,1 statins have been a recurrent object of various concerns and alarming news. For example, ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

Research indicates that many statin therapy side effects are not supported by evidence, suggesting a need for revised ...

Real-world data (RWD) is transforming clinical research, augmenting existing randomized controlled trial (RCT) data to de-risk studies and improve generalizability. With regulators setting clearer ...

Statins do not cause the majority of the conditions that have been listed in their package leaflets, including memory loss, depression, sleep disturbance, and erectile and sexual dysfunction, ...

A randomized, double-blind, three-arm, parallel group, phase 1 study to assess the pharmacokinetics, safety, and tolerability of PERT-IJS following a single dose of 420 mg intravenous infusion ...

A division of the U.S. Agency for International Development eliminated by Trump administration cuts last year was reborn ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...

Situations promoting uncertainty—including pregnancy, postpartum, parenting, or anything unknown—can help you harness and ...

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

Cardiovascular disease results in around 20 million deaths worldwide and causes around a quarter of all deaths in the UK.